Portal de Periódicos da CAPES

Australian Teledermatology experience during COVID‐19

2021; Wiley; Volume: 62; Issue: 4 Linguagem: Inglês

10.1111/ajd.13681

1440-0960

Zhi Mei Low, Laura Scardamaglia, Vanessa Morgan, Johannes S. Kern,

COVID-19 and healthcare impacts

Australasian Journal of DermatologyVolume 62, Issue 4 p. e596-e600 Letter to the Editor Australian Teledermatology experience during COVID-19 Zhi Mei Low, Zhi Mei Low orcid.org/0000-0001-5694-2273 Dermatology Department, The Royal Melbourne Hospital, Parkville, Victoria, AustraliaSearch for more papers by this authorLaura Scardamaglia, Laura Scardamaglia Dermatology Department, The Royal Melbourne Hospital, Parkville, Victoria, Australia Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, AustraliaSearch for more papers by this authorVanessa Morgan, Vanessa Morgan Dermatology Department, The Royal Melbourne Hospital, Parkville, Victoria, AustraliaSearch for more papers by this authorJohannes S Kern, Corresponding Author Johannes S Kern [email protected] orcid.org/0000-0001-6372-8048 Dermatology Department, The Royal Melbourne Hospital, Parkville, Victoria, Australia Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia Correspondence: Johannes S Kern, Dermatology Department, The Royal Melbourne Hospital, Parkville, Victoria, Australia. Email: [email protected]Search for more papers by this author Zhi Mei Low, Zhi Mei Low orcid.org/0000-0001-5694-2273 Dermatology Department, The Royal Melbourne Hospital, Parkville, Victoria, AustraliaSearch for more papers by this authorLaura Scardamaglia, Laura Scardamaglia Dermatology Department, The Royal Melbourne Hospital, Parkville, Victoria, Australia Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, AustraliaSearch for more papers by this authorVanessa Morgan, Vanessa Morgan Dermatology Department, The Royal Melbourne Hospital, Parkville, Victoria, AustraliaSearch for more papers by this authorJohannes S Kern, Corresponding Author Johannes S Kern [email protected] orcid.org/0000-0001-6372-8048 Dermatology Department, The Royal Melbourne Hospital, Parkville, Victoria, Australia Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia Correspondence: Johannes S Kern, Dermatology Department, The Royal Melbourne Hospital, Parkville, Victoria, Australia. Email: [email protected]Search for more papers by this author First published: 16 August 2021 https://doi.org/10.1111/ajd.13681Citations: 5 Funding source: None. Conflict of interest: The Royal Melbourne Hospital Foundation received an unrestricted grant for Fellowship support for a Dermatology Rural Outreach Registrar from Janssen-Cilag Pty Ltd. Janssen-Cilag Pty Ltd had no role in the study design, data collection, data analysis, interpretation of data, writing of the manuscript or publication decisions. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Ghebreyesus T. WHO Director - General's opening remarks at the media briefing on COVID-19 - 11 March 2020. 2020 [cited 2020 20 September 2020]; Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Google Scholar 2Mclean HH, Ben. Emergency Powers, Public Health and COVID-19. 2020, Parliamentary Library & Information Service: Department of Parliamentary Services. Google Scholar 3Armstrong AW, Kwong MW, Ledo L et al. Practice models and challenges in teledermatology: a study of collective experiences from teledermatologists. PLoS One 2011; 6: e28687. 10.1371/journal.pone.0028687 CASPubMedWeb of Science®Google Scholar 4Sharma A, Jindal V, Singla P et al. Will Teledermatology be the silver lining during and after COVID-19? Dermatol Ther 2020; e13643. PubMedWeb of Science®Google Scholar 5Moscarella E, Pasquali P, Cinotti E et al. A survey on teledermatology use and doctors' perception in times of COVID-19. J Eur Acad Dermatol Venereol 2020; 34: e772. 10.1111/jdv.16843 CASPubMedWeb of Science®Google Scholar 6Winters JM. A telehomecare model for optimizing rehabilitation outcomes. Telemed J E Health 2004; 10: 200–12. 10.1089/tmj.2004.10.200 PubMedWeb of Science®Google Scholar 7Abbott LM, Miller R, Janda M et al. Practice guidelines for teledermatology in Australia. Australas J Dermatol 2020; 61: e293–302. 10.1111/ajd.13301 PubMedWeb of Science®Google Scholar Citing Literature Volume62, Issue4November 2021Pages e596-e600 ReferencesRelatedInformation